Variant report
Variant | nsv1015594 |
---|---|
Chromosome Location | chr5:114117180-114140694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:114139161..114139984-chr5:114369361..114370136,2 | MCF-7 | breast: | |
2 | chr5:114133331..114134215-chr5:114369304..114370183,3 | MCF-7 | breast: | |
3 | chr5:114125530..114126082-chr5:114137895..114138833,2 | MCF-7 | breast: | |
4 | chr5:114139185..114139978-chr5:114404825..114405439,2 | MCF-7 | breast: | |
5 | chr5:114138711..114139387-chr5:114369334..114369873,2 | MCF-7 | breast: | |
6 | chr5:114125530..114126082-chr5:114137895..114138833,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10058579 | chr5:114117180-114117181 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs17137108 | chr5:114117201-114117202 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs562907034 | chr5:114117217-114117218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530407414 | chr5:114117260-114117261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73779992 | chr5:114117267-114117268 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs76665009 | chr5:114117269-114117270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532783053 | chr5:114117294-114117295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376625187 | chr5:114117335-114117336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75579688 | chr5:114117341-114117342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570318985 | chr5:114117362-114117363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4705511 | chr5:114117381-114117382 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs144919361 | chr5:114117395-114117396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147963976 | chr5:114117419-114117420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570068420 | chr5:114117448-114117449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537046123 | chr5:114117466-114117467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558851675 | chr5:114117474-114117475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75873051 | chr5:114117479-114117480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141732137 | chr5:114117532-114117533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372633245 | chr5:114117572-114117573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs71653322 | chr5:114117573-114117574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540830068 | chr5:114117592-114117593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140832825 | chr5:114117594-114117595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs3221279 | chr5:114117602-114117603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3985018 | chr5:114117603-114117604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs60726051 | chr5:114117604-114117605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550387659 | chr5:114117669-114117670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552718544 | chr5:114117672-114117673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577408706 | chr5:114117673-114117674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193150287 | chr5:114117686-114117687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183560561 | chr5:114117688-114117689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188287524 | chr5:114117706-114117707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534690627 | chr5:114117711-114117712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530577147 | chr5:114117771-114117772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545474289 | chr5:114117844-114117845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147091983 | chr5:114117848-114117849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372654100 | chr5:114117850-114117851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532651680 | chr5:114117897-114117898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566519611 | chr5:114117957-114117958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548032652 | chr5:114117958-114117959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566243948 | chr5:114117966-114117967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552825064 | chr5:114118005-114118006 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10075701 | chr5:114118027-114118028 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs372807009 | chr5:114118035-114118036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570042235 | chr5:114118060-114118061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537461617 | chr5:114118067-114118068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376097548 | chr5:114118099-114118100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79444908 | chr5:114118118-114118119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558631842 | chr5:114118158-114118159 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147999756 | chr5:114118160-114118161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370000998 | chr5:114118176-114118177 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:114110200-114118400 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr5:114112800-114118000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr5:114117800-114118800 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr5:114118000-114118400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr5:114118400-114118600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr5:114118400-114119000 | Enhancers | Adipose Nuclei | Adipose |
7 | chr5:114118600-114119000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr5:114118600-114119000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
9 | chr5:114119000-114119600 | Weak transcription | Adipose Nuclei | Adipose |
10 | chr5:114119600-114120800 | Enhancers | Adipose Nuclei | Adipose |
11 | chr5:114125400-114126000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr5:114129200-114129800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |